| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.41 | 0.007 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.095 | 0.008 |